Genesis Therapeutics collects $52M
December 3, 2020- Share:
Genesis Therapeutics has raised $52 million in a Series A led by Rock Springs Capital, with participation from investors including Menlo Ventures and Andreessen Horowitz. The Burlingame, Calif.-based company creates AI-powered technologies to accelerate the development of new medicines.
Select Additional Investors
- Share:
-
-
-
-